Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127275561 | 12727556 | 1 | I | 20160829 | 20160909 | 20160909 | EXP | NO-SUN PHARMACEUTICAL INDUSTRIES LTD-2016R1-123733 | RANBAXY | 0.00 | M | Y | 0.00000 | 20160909 | OT | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127275561 | 12727556 | 1 | PS | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | Unknown | UNK | 77032 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127275561 | 12727556 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127275561 | 12727556 | DE |
| 127275561 | 12727556 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127275561 | 12727556 | Completed suicide | |
| 127275561 | 12727556 | Decreased interest | |
| 127275561 | 12727556 | Nightmare | |
| 127275561 | 12727556 | Pain | |
| 127275561 | 12727556 | Palpitations | |
| 127275561 | 12727556 | Personality change | |
| 127275561 | 12727556 | Psychiatric symptom | |
| 127275561 | 12727556 | Social avoidant behaviour | |
| 127275561 | 12727556 | Streptokinase antibody increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |